199 related articles for article (PubMed ID: 22747490)
1. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
[TBL] [Abstract][Full Text] [Related]
2. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
Zeiser J; Gerhard R; Just I; Pich A
J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
[TBL] [Abstract][Full Text] [Related]
5. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the function of Clostridium difficile toxin B.
Reinert DJ; Jank T; Aktories K; Schulz GE
J Mol Biol; 2005 Sep; 351(5):973-81. PubMed ID: 16054646
[TBL] [Abstract][Full Text] [Related]
7. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate recognition by Clostridium difficile toxin A.
Greco A; Ho JG; Lin SJ; Palcic MM; Rupnik M; Ng KK
Nat Struct Mol Biol; 2006 May; 13(5):460-1. PubMed ID: 16622409
[TBL] [Abstract][Full Text] [Related]
9. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
Antunes A; Dupuy B
Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.
Alvin JW; Lacy DB
J Struct Biol; 2017 Jun; 198(3):203-209. PubMed ID: 28433497
[TBL] [Abstract][Full Text] [Related]
11. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
[TBL] [Abstract][Full Text] [Related]
12. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
14. Metal Ion Activation of Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B.
Genth H; Schelle I; Just I
Toxins (Basel); 2016 Apr; 8(4):109. PubMed ID: 27089365
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
16. Conformational changes and reaction of clostridial glycosylating toxins.
Ziegler MO; Jank T; Aktories K; Schulz GE
J Mol Biol; 2008 Apr; 377(5):1346-56. PubMed ID: 18325534
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent analogs of UDP-glucose and their use in characterizing substrate binding by toxin A from Clostridium difficile.
Bhattacharyya S; Kerzmann A; Feig AL
Eur J Biochem; 2002 Jul; 269(14):3425-32. PubMed ID: 12135481
[TBL] [Abstract][Full Text] [Related]
18. Processing of Clostridium difficile toxins.
Giesemann T; Egerer M; Jank T; Aktories K
J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
[TBL] [Abstract][Full Text] [Related]
19. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
20. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
